Images List Premium Download Classic

Rheumatoid Arthritis

Rheumatoid Arthritis-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Antibodies specific for il-17a fused to hyaluronan binding peptide tags
Novartis Ag
October 12, 2017 - N°20170291939

The present disclosure relates to antibodies and proteins comprising an antigen-binding portion thereof that specifically bind to the pro-inflammatory cytokine il-17a and a peptide tag that binds hyaluronan (ha). The disclosure more specifically relates to specific antibodies and proteins that are il-17a antagonists (inhibit the activities of il-17a and il-17af) and are capable of inhibiting il-17...
Synergistic composition for osteoarthritis
Laila Nutraceuticals
October 12, 2017 - N°20170290875

The present invention relates to synergistic compositions for the treatment of one or more associated conditions of arthritis or rheumatoid arthritis osteoarthritis. More particularly, novel synergistic compositions which comprises a combination of therapeutically effective amounts of: a) an alcoholic/hydroalcoholic extract of tamarindus indica seed comprising proanthocyanidins either alone or in combination with water extract of tamarindus indica seed comprising ...
Compounds and methods for kinase modulation, and indications therefor
Laila Nutraceuticals
October 05, 2017 - N°20170283423

In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on one or more of fms, kit, flt3, trka, trkb and trkc kinase protein. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of one or more of fms, ...
Rheumatoid Arthritis Patent Pack
Download 109+ patent application PDFs
Rheumatoid Arthritis Patent Applications
Download 109+ Rheumatoid Arthritis-related PDFs
For professional research & prior art discovery
inventor
  • 109+ full patent PDF documents of Rheumatoid Arthritis-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method of treatment and compositions comprising a dual pi3k delta-gamma kinase inhibitor and a ...
Rhizen Pharmaceuticals Sa
October 05, 2017 - N°20170281630

This present disclosure relates to a method of treating autoimmune, respiratory and/or inflammatory diseases or conditions, e. G., asthma, copd, rheumatoid arthritis and idiopathic pulmonary fibrosis (ipf). The method comprises administering a dual pi3k delta and gamma inhibitor and a corticosteroid. The present invention also relates to pharmaceutical compositions containing a dual pi3k delta and gamma inhibitor ...
Antibodies that bind il-23
Eli Lilly And Company
September 28, 2017 - N°20170275356

The present invention provides an antibody that binds to the p19 subunit of human il-23 and is characterized as having high affinity, selective, and neutralizing properties. The antibody is useful in the treatment or prevention of an autoimmune or inflammatory condition selected from the group consisting of consisting of multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, ankylosing spondylitis, graft-versus-host ...
Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and assay kit
Stichting Voor De Technische Wetenschappen
September 21, 2017 - N°20170269078

Peptides useful in determining the presence of autoantibodies in patients suffering from rheumatoid arthritis are disclosed.
Rheumatoid Arthritis Patent Pack
Download 109+ patent application PDFs
Rheumatoid Arthritis Patent Applications
Download 109+ Rheumatoid Arthritis-related PDFs
For professional research & prior art discovery
inventor
  • 109+ full patent PDF documents of Rheumatoid Arthritis-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibrosis or liver cirrhosis
Korea United Pharm. Inc.
September 21, 2017 - N°20170266219

The present invention relates to a pharmaceutical composition for preventing or treating liver fibrosis or liver cirrhosis, and more specifically, to a pharmaceutical composition for preventing or treating liver fibrosis or liver cirrhosis comprising a gold-containing agent. The pharmaceutical composition of the present invention, by comprising the gold-containing agent as an active ingredient, not only promotes m2-type transformation of ...
Treatment for rheumatoid arthritis
Medimmune Limited
September 14, 2017 - N°20170260276

Treatment of rheumatoid arthritis (ra) to provide clinical benefit in patients, including decrease in das28-crp by more than 1. 2 and/or improvement determined by acr20, acr50 or acr70, comprising administering therapeutic antibody mavrilimumab.
Compositions for expanding regulatory t cells (treg), and treating autoimmune and inflammatory diseases and conditions
The Regents Of The University Of California
September 14, 2017 - N°20170260236

Provided are compositions, including isolated, synthetic or recombinant peptides for: expanding regulatory t cells (treg) populations; for treating or ameliorating a vascular inflammation, and kawasaki disease (kd) or a pediatric acute vasculitis of the coronary arteries, including vascular coronary abnormalities, and acute or chronic vascular inflammatory abnormalities, and methods for making and using them. Provided are immunotherapies for promoting expansion ...
Methods, agents and compositions for treatment of inflammatory conditions
Betanien Hospital
September 14, 2017 - N°20170258867

The present invention relates to the screening, diagnosis, prognostic evaluation, and treatment or prevention of age associated inflammation, chronic inflammation, and inflammatory diseases. In particular, the present invention relates to treating or preventing inflammatory diseases (e. G. Rheumatoid arthritis or spondyloarthritis) or patients with inflammatory peripheral gnrh with gnrh antagonists or drugs that lower the effects of gnrh.
Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or ...
Industrial Technology Research Institute
September 14, 2017 - N°20170258865

The present disclosure provides a pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis, including: an effective amount of an extract of a plant belonging to rutaceae as an effective ingredient for treating or alleviating the autoimmune disease and/or complication thereof and/or nephritis, wherein the autoimmune disease is selected from a ...
Corticosteroid formulations and methods for the treatment of joint pain in patients with diabetes
Flexion Therapeutics, Inc.
September 14, 2017 - N°20170258815

This invention relates to the use of corticosteroids in patients with diabetes, including patients with type 2 diabetes, to treat pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis without increasing or otherwise significantly impacting blood glucose concentrations in diabetic patients, and to slow, arrest or reverse structural damage to tissues caused by an inflammatory disease, for ...
Alkyl linked quinolinyl modulators of rorγt
Flexion Therapeutics, Inc.
September 14, 2017 - N°20170258782

The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating rorγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.
Rheumatoid Arthritis Patent Pack
Download 109+ patent application PDFs
Rheumatoid Arthritis Patent Applications
Download 109+ Rheumatoid Arthritis-related PDFs
For professional research & prior art discovery
inventor
  • 109+ full patent PDF documents of Rheumatoid Arthritis-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Heterocyclic compound
Applied Molecular Evolution, Inc.
September 07, 2017 - N°20170253591

[wherein each symbol is as described in the description] or a salt thereof, which has an rorγt inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like.
Compositions for improving the health related quality of life of rheumatoid arthritis patients
Regeneron Pharmaceuticals, Inc.
September 07, 2017 - N°20170252434

The present invention provides compositions and methods of for improving the health-related quality of life of a subject suffering from rheumatoid arthritis, comprising administering to the subject an effective amount of sarilumab.
Probiotic bifidobacterium adolescentis strains
Chr. Hansen A/s
September 07, 2017 - N°20170252382

The present invention relates to novel isolated strains of bifidobacterium adolescentis which are capable of i) increasing the trans-epithelial electrical resistance (ter) of a caco-2 cell monolayer after 10 h treatment to more than 120% of ter at treatment start, ii) inducing secretion of >200 pg/ml of il-10, and/or iii) inducing an il-10:il-12 ratio>1 when co-incubated ...
Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry ...
The Board Of Trustees Of The University Of Arkansas Acting For And On Behalf Of The Universit
September 07, 2017 - N°20170252347

A composition and method of treatment of neuromuscular, neuromuscular degenerative, neurodegenerative, autoimmune, developmental, traumatic, hearing loss related, and/or metabolic diseases, including spinal muscular atrophy (sma) syndrome (sma1, sma2, sma3, and sma4, also called type i, ii, iii and iv), traumatic brain injury (tbi), concussion, keratoconjunctivitis sicca (dry eye disease), glaucoma, sjogren's syndrome, rheumatoid arthritis, post-lasik surgery, anti-depressants use, wolfram ...
Pyrazolothiazole compound and medicine comprising same
The Board Of Trustees Of The University Of Arkansas Acting For And On Behalf Of The Universit
September 07, 2017 - N°20170252341

The compound of the invention has jak1 inhibitory activity, and thus, immunosuppressive effect, anti-inflammatory effect and anti-proliferative effect, and is useful in the treatment of the diseases, for example, rheumatoid arthritis, inflammatory bowel disease, psoriasis and vasculitis, bronchial asthma, chronic obstructive pulmonary disease and eosinophilic sinusitis, nasal polyp.
Modulation of ptpra to treat arthritis
The Regents Of The University Of California
August 31, 2017 - N°20170247469

Presented is a method for treating inflammation and autoimmune diseases through the use of a phosphatase rheumatoid arthritis (pt-pra) antagonist.
Methods of treating inflammatory and autoimmune diseases with natalizumab
Biogen Ma, Inc.
August 31, 2017 - N°20170247457

Natalizumab is a safe and efficacious treatment for inflammatory and autoimmune diseases, such as multiple sclerosis, crohn's disease, and rheumatoid arthritis. Rare occurrences of progressive multifocal leucoencephalopathy during treatment suggest the possibility that it may be related to natalizumab treatment. Monitoring for jcv and informing caregivers and patients about the manifestations of progressive multifocal leucoencephalopathy can improve the safety of ...
(z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide tablet formulations with improved stability
Sanofi
August 31, 2017 - N°20170247319

The invention relates to solid pharmaceutical compositions comprising (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.
Loading